𝔖 Bobbio Scriptorium

✦ LIBER ✦

Costs of care in a mild-to-moderate Alzheimer clinical trial sample: Key resources and their determinants

✍ Scribed by Anders Gustavsson; Francoise Cattelin; Linus Jönsson

Book ID: 118466768
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 317 KB
Volume: 7
Category: Article
ISSN: 1552-5260
DOI: 10.1016/j.jalz.2010.06.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combined treatment with cerebrolysin and

Combined treatment with cerebrolysin and donepezil in mild to moderate alzheimer's disease: Results of a double-blind, randomized clinical trial

✍ Anton Alvarez; Ramon Cacabelos; Manuel Aleixandre; Carlos Linares; Elias Granizo 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 169 KB

Effect of combination therapy with meman

Effect of combination therapy with memantine and rivastigmine transdermal patch on BPSD in patients with mild-to-moderate Alzheimer's disease: A 24-week prospective, multicenter, randomized, open-label clinical trial

✍ Na, Hae Ri; Choi, Seong; Yoon, Soo Jin; Park, Kyung Won; Kim, Byeong Chae; Lee, 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Effect of combination therapy with meman

Effect of combination therapy with memantine and rivastigmine patch on agitation behavior in patients with mild-to-moderate Alzheimer's disease: A 24-week prospective, multicenter, randomized, open-label clinical trial

✍ Yoon, Soo Jin 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 55 KB

An over the counter moisturizer is as cl

An over the counter moisturizer is as clinically effective as, and more cost-effective than, prescription barrier creams in the treatment of children with mild to moderate atopic dermatitis: A randomized, controlled trial

📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Safety, tolerability and immunogenicity

Safety, tolerability and immunogenicity of an immunotherapeutic vaccine (vanutide cridificar [ACC-001]) and the QS-21 adjuvant in Japanese individuals with mild-to-moderate Alzheimer's disease: A phase IIa, multicenter, randomized, adjuvant and placebo clinical trial

✍ Arai, Heii; Suzuki, Hideo; Yoshiyama, Tamotsu; Lobello, Kasia; Peng, Yahong; Liu 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 53 KB